Do short-term markers of treatment efficacy predict long-term sequelae of pelvic inflammatory disease?
- 31 January 2008
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 198 (1) , 30.e1-30.e7
- https://doi.org/10.1016/j.ajog.2007.05.021
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Lower quality of life among women with chronic pelvic pain after pelvic inflammatory disease*1Obstetrics & Gynecology, 2003
- Association between Mycoplasma genitalium and acute endometritisThe Lancet, 2002
- Evaluation of ofloxacin in the treatment of laparoscopically documented acute pelvic inflammatory disease (salpingitis)Infectious Diseases in Obstetrics and Gynecology, 1999
- Oral contraception and the recognition of endometritisAmerican Journal of Obstetrics and Gynecology, 1997
- Oral Clindamycin and Ciprofloxacin Versus Intramuscular Ceftriaxone and Oral Doxycycline in the Treatment of Mild-to-Moderate Pelvic Inflammatory Disease in OutpatientsClinical Infectious Diseases, 1997
- Comparison of Three Regimens Recommended by the Centers for Disease Control and Prevention for the Treatment of Women Hospitalized with Acute Pelvic Inflammatory DiseaseClinical Infectious Diseases, 1994
- Grading the severity of chronic painPAIN®, 1992
- Histopathology of Chlamydia trachomatis salpingitis after primary and repeated reinfections in the monkey subcutaneous pocket modelReproduction, 1989
- Treatment of acute salpingitis with sulbactam/ampicillinInternational Journal of Gynecology & Obstetrics, 1989
- Acute Pelvic Inflammatory DiseaseSexually Transmitted Diseases, 1977